Drug intelligence / Profile preview

compound yew capsule

Development stage
Phase 4
Lead developer
Guang'anmen Hospital
Administration
Oral
01

Overview

Compound yew capsule is a Chinese patent medicine (CPM) primarily used as an adjuvant or maintenance therapy for various malignancies, including non-small cell lung cancer (NSCLC), breast cancer, and ovarian cancer. The formulation is composed of extracts from *Taxus chinensis* (Chinese yew), which contains natural taxanes such as paclitaxel, along with other traditional Chinese medicinal herbs including *Panax ginseng*, *Astragalus membranaceus*, and *Ganoderma lucidum*. The taxane component acts by stabilizing microtubules, thereby inhibiting mitosis and inducing apoptosis in cancer cells. The additional herbal components are intended to enhance immune function and mitigate the side effects of chemotherapy, aligning with the TCM principle of "strengthening the body's resistance and eliminating pathogenic factors." It is frequently evaluated in China for patients with "Qi deficiency and phlegm stasis" syndromes to improve quality of life and prolong survival.

Brand names
Fufang Hongdoushan Jiaonang
Other names
Compound Taxus Capsule
02

Targets

TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on compound yew capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on compound yew capsule.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call